GAiT.Global – The Global Alliance for iPSC Therapies

Janet Lambert @jlynchlambert·

23 Apr 1120605101071192071

Stunning key takeaway from Guido Rasi’s keynote speech - EMA shortly anticipates 10+ #ATMP approvals a year. #Med19 #RegenMed @alliancerm @EMA_News

Reply on Twitter 1120605101071192071 Retweet on Twitter 11206051010711920717 Like on Twitter 11206051010711920717 Twitter 1120605101071192071

23 Apr 1120592198624477184

#Med19 keynote speaker Guido Rasi, Director General of the EMA, discusses the challenges regulators face with innovative medicines: “We need a completely new generation of experts. Novel technologies will need to have novel expertise”. Watch now:

Webcast | Cell & Gene Meeting on the Med

View the full webcast including panels, company presentations and keynote talks from the Cell & Gene Meeting on the Mediterranean.

bit.ly

Reply on Twitter 1120592198624477184 Retweet on Twitter 11205921986244771843 Like on Twitter 11205921986244771843 Twitter 1120592198624477184

23 Apr 1120612089402466304

Key takeaways from our panel on what is needed for forward-looking #ATMP commercial strategies: an early start on preparation, robust service planning to minimise disturbance to systems, enthusiastic collaboration and for stakeholders to share risk. #Med19

Reply on Twitter 1120612089402466304 Retweet on Twitter 11206120894024663044 Like on Twitter 11206120894024663043 Twitter 1120612089402466304

23 Apr 1120672535862042626

Closing thoughts from our panel on opportunities and challenges in the pricing and reimbursement landscape: it is critical for companies to be transparent, consider early the various issues which may impact pricing, and articulate the value of #ATMPs to patients and payors #Med19

Reply on Twitter 1120672535862042626 Retweet on Twitter 11206725358620426265 Like on Twitter 11206725358620426265 Twitter 1120672535862042626

23 Apr 1120604474140176384

“Everyone’s in it together, If we don’t ensure access to patients we’ve all failed … a shared responsibility is being recognised across the system” - Dan Faga, CBO of @Spark_tx in our plenary session ‘Commercial strategies from pathfinders in the industry' #Med19

Reply on Twitter 1120604474140176384 Retweet on Twitter 11206044741401763846 Like on Twitter 11206044741401763844 Twitter 1120604474140176384

23 Apr 1120615515448328194

At Cell and Gene Therapy Catapult today for meetings scientific, administrative, and financial

Reply on Twitter 1120615515448328194 Retweet on Twitter 1120615515448328194 Like on Twitter 1120615515448328194 Twitter 1120615515448328194

18 Apr 1118924338055479297

Understanding and innovating in cell therapy quality control: an interview with Stephen Sullivan, GAiT #regenmed

Understanding and innovating in cell therapy quality control: an interview with Stephen Sullivan, GAiT

Stephen Sullivan (GAiT) reflects on the evolution of quality control in the field of cell therapy, and discusses what the future may hold and what obs...

www.regmednet.com

Reply on Twitter 1118924338055479297 Retweet on Twitter 11189243380554792972 Like on Twitter 11189243380554792974 Twitter 1118924338055479297

17 Apr 1118453815219507200

Human iPSC-derived MSCs from aged individuals acquire a rejuvenation signature

The use of primary mesenchymal stem cells (MSCs) is fraught with ageing-related shortfalls such as limited expansion and early senescence. Human induc...

www.sciencedaily.com

Reply on Twitter 1118453815219507200 Retweet on Twitter 1118453815219507200 Like on Twitter 1118453815219507200 Twitter 1118453815219507200